FDA Determines Regulatory Review Period for IMPELLA RP FLEX WITH SMART ASSIST

Summary

The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for the patent extension of IMPELLA RP FLEX WITH SMART ASSIST, a medical device, following submissions to the US Patent and Trademark Office (USPTO).